Results 171 to 180 of about 20,577 (234)

An orexin-receptor-2-mediated heart-brain axis in cardiac pain. [PDF]

iScience
Jiao H, Wang Y, Fu K, Xiao X, Jia MQ, Sun J, Wang J, Zhu G, Lyu D, Lu Q, Peng Y, Lv J, Su L, Gao Y.   +13 more
europepmc   +1 more source

TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men. [PDF]

Anesthesiology
van Lemmen M, Dahan A, Hang Y, Jansen SC, Lu H, Naylor M, Olsson T, Sheikh S, Sullivan D, Tolkoff M, van der Schrier R, van Velzen M, von Rosenstiel P, Wu RL, Meyer S.   +14 more
europepmc   +1 more source

The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report. [PDF]

Clin Case Rep
Campbell EJ, Bonomo Y, Collins L, Norman A, O'Neill H, Streitberg A, Galloway K, Kyoong A, Perkins A, Pastor A, Lawrence AJ.   +10 more
europepmc   +1 more source

Effects of methamphetamine on actigraphy-based sleep parameters in female rhesus monkeys: Orexin receptor mechanisms. [PDF]

Drug Alcohol Depend
Borgatti DA, Rowlett JK, Berro LF.
europepmc   +1 more source

Sulfonamide Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and Hypersomnia. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Whole Brain Mapping of Orexin Receptor mRNA Expression Visualized by Branched In Situ Hybridization Chain Reaction. [PDF]

eNeuro
Tsuneoka Y, Funato H.
europepmc   +1 more source

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. [PDF]

Pharmaceuticals (Basel)
Cicala G, Barbieri MA, Russo G, Salvo F, Spina E.   +4 more
europepmc   +1 more source